NCT07173322 The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
| NCT ID | NCT07173322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Blood Cancer United |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-02-09 |
| Primary Completion | 2026-02-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-02-09 with a primary completion date of 2026-02-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received/are receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.
Eligibility Criteria
* any cancer patient * at least 18 years of age * with a history of receiving CAR-T Cell treatment. less than 18 years old. \-
Contact & Investigator
Nina Logan, MD
PRINCIPAL INVESTIGATOR
The Leukemia and Lymphoma Society
Frequently Asked Questions
Who can join the NCT07173322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07173322 currently recruiting?
Yes, NCT07173322 is actively recruiting participants. Contact the research team at Janaela.Scott@lls.org for enrollment information.
Where is the NCT07173322 trial being conducted?
This trial is being conducted at Rye, United States.
Who is sponsoring the NCT07173322 clinical trial?
NCT07173322 is sponsored by Blood Cancer United. The principal investigator is Nina Logan, MD at The Leukemia and Lymphoma Society. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.